Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice

International Journal of Molecular Medicine

Volumn 26, Issue 1, 2010, Pages 39-44

  Yukawa, Kazunori ^a   Tanaka, Tetsuji ^b   Kishino, Masanori ^b   Yoshida, Kenji ^a   Takeuchi, Noriko ^a   Ito, Takuji ^a   Takamatsu, Hyota ^c   Kikutani, Hitoshi ^c   Kumanogoh, Atsushi ^c  

^a MEIJO UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Neovascularization; Semaphorin

Indexed keywords

APOLIPOPROTEIN E; CD31 ANTIGEN; ISOLECTIN B4; PLEXIN; PLEXIN B1 RECEPTOR; REACTIVE OXYGEN METABOLITE; SEMAPHORIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; GENE DELETION; GENE INACTIVATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LEUKOCYTE; LYMPHOID CELL; MACROPHAGE; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 77954749287     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000432     Document Type: Article

References (36)

1. Carmeliet P: Angiogenesis in health and disease. Nature Med 9: 653-660, 2003.
2. Zhang Y, Cliff WJ, Schoefl GI and Higgins G: Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 143: 164-172, 1993. (Pubitemid 24058170)
3. Kumamoto M, Nakashima Y and Sueishi K: Intimal neovascularization in human coronary atherosclerosis: Its origin and pathophysiological significance. Hum Pathol 26: 450-456, 1995.
4. Barger AC, Beeuwkes R 3rd, Lainey LL and Silverman KJ: Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310: 175-177, 1984.
5. Moreno PR, Purushothaman KR, Sirol M, Levy AP and Fuster V: Neovascularization in human atherosclerosis. Circulation 113: 2245-2252, 2006.
6. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB and Schwartz SM: Angiogenesis in human coronary atherosclerosis plaques. Am J Pathol 145: 883-894, 1994. (Pubitemid 24320606)
7. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo K-M, Gillies S, Javaherian K and Folkman J: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 100: 4736-4741, 2003.
8. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV and Virmani R: Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349: 2316-2325, 2003.
9. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W and Folkman J: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99: 1726-1732, 1999.
10. Jonsson-Rylander AC, Nilsson T, Fritsche-Danielson R, Hammarstrom A, Behrendt M, Andersson JO, Lindgren K, Andersson AK, Wallbrandt P, Rosengren B, Brodin P, Thelin A, Westin A, Hurt-Camejo E and Lee-Sogaard CH: Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 25: 180-185, 2005.
11. Hansson GK and Libby P: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6: 508-519, 2006.
12. Mach F, Schönbeck U, Bonnefoy JY, Pober JS and Libby P: Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Induction of collagenase, stromelysin, and tissue factor. Circulation 96: 396-399, 1997.
13. Mach F, Schönbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS and Libby P: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 94: 1931-1936, 1997.
14. Mach F, Schönbeck U, Sukhova GK, Atkinson E and Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394: 200-203, 1998.
15. Lutgens E, Gorelik L, Daemen MJ, deMuinck ED, Grewal IS, Koteliansky VE and Flavell RA: Requirement for CD154 in the progression of atherosclerosis. Nat Med 11: 1313-1316, 1999.
16. Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, Araki H, Hirata H, Iwahori K, Uchida J, Yasui T, Matsumoto M, Yoshida K, Yakura H, Pan C, Parnes JR and Kikutani H: Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13: 621-631, 2000.
17. Raper JA: Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 10: 88-94, 2000.
18. Kruger RP, Aurandt J and Guan KL: Semaphorins command cells to move. Nat Rev Mol Cell Biol 6: 789-800, 2005.
19. Basile JR, Afkhami T and Gutkind JS: Semaphorin 4D/Plexin-B1 induces endothelial cell migration through the activation of PYK2, src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol 25: 6889-6898, 2005.
20. Delaire S, Billard C, Tordjman R, Chedotal A, Elhabazi A, Bensussan A and Boumsell L: Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 166: 4348-4354, 2001.
21. Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp RJ, Schiavon V, Tamagnone L, Thomasset N, Bensussan A and Boumsell L: Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int Immunol 17: 439-447, 2005.
22. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, Comoglio PM, Bussolino F and Giordano S: Sema4D induces angiogenesis through Met requirement by plexin B1. Blood 105: 4321-4329, 2005.
23. Basil JR, Barac A, Zhu T, Guan KL and Gutkind JS: Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 64: 5212-5224, 2004.
24. Basile JR, Castilho RM, Williams VP and Gutkind JS: Semaphorin 4D provides a link between axon guidance process and tumor-induced angiogenesis. Proc Natl Acad Sci USA 103: 9017-9022, 2006.
25. Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, Yasui T, Yukawa K, Ikawa M, Okabe M, Parnes JR, Yoshida K and Kikutani H: The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cells activation in CD100-deficient mice. Immunity 13: 633-642, 2000.
26. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM and Maeda N: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89: 4471-4475, 1992.
27. Dougherty A and Whitman SC: Quantification of atherosclerosis in mice. In: Methods in Molecular Biology, vol. 209: Transgenic Mouse Methods and Protocols. Hofker MH and van Deursen J (eds). Humana Press Inc., Totowa, pp293-309, 2002.
28. Lim KY, Ryan EA, Wong PKY and Yuen P-H: Studies on the pathology, especially brain hemorrhage and angioendotheliomas, induced by two new mos-containing viruses. J NeuroVirol 6: 106-120, 2000.
29. Zhu L, Stalker TJ, Fong KP, Jiang H, Tran A, Crichton I, Lee EK, Neeves KB, Maloney SF, Kikutani H, Kumanogoh A, Pure E, Diamond SL and Brass LF: Disruption of Sema4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arterioscler Thromb Vasc Biol 29: 1039-1045, 2009.
30. Massberg S, Schrzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, Kennerknecht E, Rudelius M, Sauer S, Braun S, Kremmer E, Emambokus NR, Frampton J and Gawaz M: Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112: 1180-1188, 2005.
31. Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilficker PR and Dake MD: Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7: 425-429, 2001.
32. Schönbeck U, Sukhova GK, Graber P, Coulter S and Libby P: Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155: 1281-1291, 1999. (Pubitemid 29488935)
33. Simonini A, Moscucci M, Muller DW, Bates ER, Pagani FD, Burdick MD and Strieter RM: IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 101: 1519-1526, 2000. (Pubitemid 30180887)
34. Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg E, Afonyushkin T, Gruber F, Breuss J, Minchenko A, Mechtcheriakova D, Hohensinner P, Rychli K, Wojta J, Resink T, Erne P, Binder BR and Leitinger N: Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ Res 99: 900-908, 2006.
35. Moulton KS: Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 3: 225-233, 2001.
36. Komatsu M and Ruoslahti E: R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. Nat Med 11: 1346-1350, 2005.